OCUL
Ocular Therapeutix, Inc. · Healthcare
Chief Medical Officer Rabia Gurses Ozden sold $31K of Ocular Therapeutix, Inc.
Sold$30,842
$4.86Price
6,346Shares
−4%Stake
What OCUL did after the filing
- The stock from Tue, Feb 6 close, $5.04
- +96.4%
- S&P 500, same days
- +5.7%
Measured over 30 trading days, to the Mar 20 close.
Traded Mon, Feb 5. Filed Tue, Feb 6, 1:32 PM ET, during the session. Returns use the Feb 6 close and the Mar 20 close. Not investment advice.